Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Becker, JC; Schrama, D.
Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
J Invest Dermatol. 2011; 131(6):1185-1187
Doi: 10.1038/jid.2011.94
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Becker Jürgen Christian
- Co-authors Med Uni Graz
- Schrama David
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The hypopigmenting agent monobenzone induces inflammatory responses only in pigmented skin as well as depigmentation in areas not directly exposed to the drug. Both observations have been ascribed to the possible induction of adaptive immune responses against melanocytes. In this issue, van den Boorn et al. provide direct evidence confirming this hypothesis. Since the monobenzone-induced immune responses target melanocyte-differentiation antigens, this report opens the opportunity for a simple and instantaneous deployable immunotherapy of melanoma.
- Find related publications in this database (using NLM MeSH Indexing)
- Adaptive Immunity - drug effects
- Cell Differentiation -
- Humans -
- Hydroquinones - pharmacology
- Hydroquinones - therapeutic use
- Immune Tolerance - drug effects
- Immunotherapy -
- Melanocytes - cytology
- Melanocytes - drug effects
- Melanocytes - immunology
- Melanoma - therapy
- Skin Pigmentation - drug effects